NATHAN ROBERT EVERY, MD
Osteopathic Medicine in Seattle, WA
License number
Washington MD00027630
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
Va Puget Sound Healthcare System 1660 S. COLUMBIAN WAY, Seattle, WA 98108
Phone
(206) 764-2008
(206) 985-4421
(206) 985-4421
Personal information
See more information about NATHAN ROBERT EVERY at radaris.comName
Address
Phone
3887 44Th Ave NE, Seattle, WA 98105
3887 44Th Ave NE, Seattle, WA 98105
3887 44Th St, Seattle, WA 98105
3843 20Th St, Seattle, WA 98106
3323 Laurelhurst Dr, Seattle, WA 98105
Professional information
Dr. Nathan R Every, Seattle WA - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
1660 S Columbian Way, Seattle 98108
(206) 764-2008 (Phone)
(206) 764-2008 (Phone)
Conditions:
Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Congestive Heart Failure, Coronary Artery Disease (CAD), Hypertension, Mitral Valve Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 2008, Internal Medicine, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Emory University
Graduated: 1988
University Of Washington
Emory University
Graduated: 1988
University Of Washington
Diuretic Aerosols And Methods Of Making And Using Them
US Patent:
2004010, Jun 3, 2004
Filed:
Nov 12, 2003
Appl. No.:
10/712365
Inventors:
Nathan Every - Seattle WA, US
Ron Hale - Woodside CA, US
Amy Lu - Los Altos CA, US
Joshua Rabinowitz - Mountain View CA, US
Ron Hale - Woodside CA, US
Amy Lu - Los Altos CA, US
Joshua Rabinowitz - Mountain View CA, US
Assignee:
Alexza Molecular Delivery Corporation - Palo Alto CA
International Classification:
A61L009/04, A61K031/58
US Classification:
424/045000, 514/173000
Abstract:
Described herein are diuretic condensation aerosols and methods of making and using them. Kits for delivering a condensation aerosol are also described. The diuretic aerosols typically comprise diuretic condensation aerosol particles that comprise a diuretic compound. In some variations the diuretic compound is selected from the group consisting of bumetanide, ethacrynic acid, furosemide, muzolimine, spironolactone, torsemide, triamterene, tripamide, BG 9928, and BG 9719. Methods of treating edema using the described aerosols are also provided. In general, the methods typically comprise the step of administering a therapeutically effective amount of diuretic condensation aerosol to a person with edema. The diuretic condensation aerosol may be administered in a single inhalation, or may be administered in more than one inhalation. Methods of forming a diuretic condensation aerosol are also described. The methods typically comprise the steps of providing a diuretic composition, vaporizing the composition to form a vapor, and then condensing the diuretic composition vapor.
Satiation Devices And Methods
US Patent:
2013029, Nov 7, 2013
Filed:
Jul 5, 2013
Appl. No.:
13/936132
Inventors:
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks, JR. - Durham NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks, JR. - Durham NC, US
International Classification:
A61F 5/00
US Classification:
604 9
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
Satiation Devices And Methods
US Patent:
2003004, Feb 27, 2003
Filed:
Aug 27, 2001
Appl. No.:
09/940110
Inventors:
Richard Stack - Chapel Hill NC, US
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks - Durham NC, US
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks - Durham NC, US
International Classification:
A61F002/04
US Classification:
623/023700, 623/902000
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
Satiation Devices And Methods
US Patent:
7354454, Apr 8, 2008
Filed:
Jul 16, 2004
Appl. No.:
10/892973
Inventors:
Richard S. Stack - Chapel Hill NC, US
Richard A. Glenn - Chapel Hill NC, US
Trevor J. Moody - Seattle WA, US
Fred E. Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
Richard A. Glenn - Chapel Hill NC, US
Trevor J. Moody - Seattle WA, US
Fred E. Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
Assignee:
Synecor, LLC - Durham NC
International Classification:
A61F 2/04
US Classification:
623 2365, 623 7, 600 37, 604 7, 604 8, 604264
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
Satiation Devices And Methods
US Patent:
2003019, Oct 23, 2003
Filed:
Jun 9, 2003
Appl. No.:
10/457137
Inventors:
Richard Stack - Chapel Hill NC, US
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks - Durham NC, US
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks - Durham NC, US
International Classification:
A61F002/04
US Classification:
623/023650, 623/023700
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
Satiation Devices And Methods
US Patent:
2013031, Nov 21, 2013
Filed:
Jan 4, 2013
Appl. No.:
13/734905
Inventors:
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks, JR. - Durham NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks, JR. - Durham NC, US
Assignee:
Barosense, Inc. - Redwood City CA
International Classification:
A61F 5/00
US Classification:
604 9
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
Obesity Treatment Method
US Patent:
7628821, Dec 8, 2009
Filed:
Aug 2, 2005
Appl. No.:
11/195204
Inventors:
Richard S. Stack - Chapel Hill NC, US
Fred E. Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William L. Athas - Durham NC, US
Michael S. Williams - Santa Rosa CA, US
Richard A. Glenn - Chapel Hill NC, US
John Lunsford - San Carlos CA, US
Dan Balbierz - Redwood City CA, US
Fred E. Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William L. Athas - Durham NC, US
Michael S. Williams - Santa Rosa CA, US
Richard A. Glenn - Chapel Hill NC, US
John Lunsford - San Carlos CA, US
Dan Balbierz - Redwood City CA, US
Assignee:
Barosense, Inc. - Redwood City CA
International Classification:
A61B 19/00, A61F 2/04
US Classification:
623 2364, 623 2365, 128898, 604 9
Abstract:
A prosthetic device is described that is positionable within the gastro-esophageal junction region of a patient. The prosthetic device includes a proximal opening and a distal orifice that is adjustable in size prior to and/or following implantation. During use, the prosthetic device is attached to tissue of the gastro-esophageal junction region of the patient, with the device positioned such that food ingested by the patient passes from the esophagus through the proximal opening into the interior of the prosthetic device, and eventually exits the prosthetic device via the distal opening.
Satiation Devices And Methods
US Patent:
2003019, Oct 23, 2003
Filed:
Jun 9, 2003
Appl. No.:
10/457144
Inventors:
Richard Stack - Chapel Hill NC, US
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks - Durham NC, US
Richard Glenn - Chapel Hill NC, US
Trevor Moody - Seattle WA, US
Fred Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
William Eubanks - Durham NC, US
International Classification:
A61F002/04
US Classification:
623/023650, 623/023700
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
Satiation Devices And Methods
US Patent:
7833280, Nov 16, 2010
Filed:
Apr 8, 2008
Appl. No.:
12/099290
Inventors:
Richard S. Stack - Chapel Hill NC, US
Richard A. Glenn - Chapel Hill NC, US
Trevor J. Moody - Seattle WA, US
Fred E. Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
Richard A. Glenn - Chapel Hill NC, US
Trevor J. Moody - Seattle WA, US
Fred E. Silverstein - Seattle WA, US
Nathan Every - Seattle WA, US
Assignee:
Barosense, Inc. - Redwood City CA
International Classification:
A61F 2/04
US Classification:
623 2365, 623 237, 604 7, 604 8, 604264, 600 37
Abstract:
A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.